ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 212 filers reported holding ALKERMES PLC in Q4 2020. The put-call ratio across all filers is 5.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,412,047 | -18.2% | 300,323 | -8.6% | 0.03% | -11.8% |
| Q2 2023 | $10,283,490 | +7.6% | 328,546 | -3.1% | 0.03% | +3.0% |
| Q1 2023 | $9,555,170 | +11.3% | 338,956 | +3.2% | 0.03% | +6.5% |
| Q4 2022 | $8,583,679 | -41.8% | 328,499 | -50.3% | 0.03% | +6.9% |
| Q3 2022 | $14,748,103 | -23.3% | 660,466 | +2.3% | 0.03% | -19.4% |
| Q2 2022 | $19,240,323 | +40.6% | 645,876 | +24.2% | 0.04% | +89.5% |
| Q1 2022 | $13,683,916 | +148.6% | 520,100 | +191.4% | 0.02% | +26.7% |
| Q3 2021 | $5,505,000 | +30.1% | 178,500 | +3.4% | 0.02% | +150.0% |
| Q2 2021 | $4,232,000 | +162.5% | 172,600 | +100.0% | 0.01% | +20.0% |
| Q1 2021 | $1,612,000 | +0.8% | 86,300 | +7.6% | 0.01% | 0.0% |
| Q4 2020 | $1,600,000 | +412.8% | 80,200 | +326.6% | 0.01% | +400.0% |
| Q3 2020 | $312,000 | -57.3% | 18,800 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $730,000 | -89.8% | 37,600 | -84.5% | 0.00% | -96.8% |
| Q4 2018 | $7,150,000 | -41.5% | 242,295 | -15.9% | 0.03% | -31.1% |
| Q3 2018 | $12,221,000 | +3.1% | 287,975 | 0.0% | 0.04% | 0.0% |
| Q2 2018 | $11,853,000 | -16.5% | 287,975 | +17.6% | 0.04% | -21.1% |
| Q1 2018 | $14,189,000 | -15.6% | 244,793 | -20.3% | 0.06% | -13.6% |
| Q4 2017 | $16,819,000 | +98.2% | 307,318 | +84.1% | 0.07% | +78.4% |
| Q3 2017 | $8,487,000 | -35.5% | 166,926 | +0.6% | 0.04% | -36.2% |
| Q4 2015 | $13,166,000 | +32.5% | 165,863 | -2.1% | 0.06% | +41.5% |
| Q3 2015 | $9,936,000 | -52.7% | 169,349 | -48.1% | 0.04% | -51.2% |
| Q2 2015 | $20,993,000 | +5.5% | 326,290 | 0.0% | 0.08% | +2.4% |
| Q1 2015 | $19,894,000 | +8.8% | 326,290 | +4.5% | 0.08% | +12.3% |
| Q4 2014 | $18,280,000 | +43.0% | 312,154 | +4.7% | 0.07% | +32.7% |
| Q3 2014 | $12,781,000 | -31.8% | 298,136 | -19.9% | 0.06% | -29.5% |
| Q2 2014 | $18,729,000 | +9.6% | 372,117 | -4.0% | 0.08% | +5.4% |
| Q1 2014 | $17,093,000 | +30.0% | 387,695 | +19.9% | 0.07% | +25.4% |
| Q4 2013 | $13,153,000 | +28.2% | 323,477 | +6.0% | 0.06% | +15.7% |
| Q3 2013 | $10,259,000 | +277.3% | 305,136 | +221.9% | 0.05% | +264.3% |
| Q2 2013 | $2,719,000 | – | 94,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |